Peel Hunt reiterated their buy rating on shares of Craneware (LON:CRW) in a research report report published on Monday morning. They currently have a GBX 1,800 ($24.23) target price on the stock.
Separately, N+1 Singer reissued a hold rating on shares of Craneware in a research note on Tuesday, September 5th.
Craneware (CRW) opened at GBX 1,473 ($19.83) on Monday. Craneware has a 12 month low of GBX 1,065 ($14.33) and a 12 month high of GBX 1,885 ($25.37).
ILLEGAL ACTIVITY WARNING: This article was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.dispatchtribunal.com/2017/12/08/craneware-crw-stock-rating-reaffirmed-by-peel-hunt.html.
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.
Receive News & Ratings for Craneware plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware plc and related companies with MarketBeat.com's FREE daily email newsletter.